narrow-moat iqvia report robust top-lin growth
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim
price data apr
rate updat apr
currenc amount express
methodolog valu compani
contract research organ iqvia start year well
billion revenu slightli surpass
expect repres growth constant
currenc report despit currenc headwind
termin major trial manag maintain
full-year guidanc affirm oper
environ clinic develop servic remain
strong adjust near-term revenu outlook
technolog analyt segment perform
ahead expect anticip low- mid-
single-digit increas fair valu estim strong
research
develop segment support intang
asset switch cost underpin compani
technolog
technolog analyt segment post billion
revenu nearli constant currenc
report call manag point
one third technolog segment legaci im data
busi grow leav real-world evid
iqvia custom relationship manag platform
name oce drive segment double-digit growth
sale product servic acceler
quicker expect result organ growth
technolog segment quarter compar
histor level
research develop segment contribut
billion revenu quarter constant currenc
report backlog grew billion
adjust million termin major late-
stage alzheim trial even without adjust
cancel trial quarterli backlog growth seem
slow slightli sequenti basi said
adjust backlog growth trail basi
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
iqvia result merger quintil lead global contract
research organ im health lead healthcar data
analyt provid cro segment focus primarili provid
outsourc late-stag clinic trial pharmaceut devic
technolog servic client healthcar industri includ
pharmaceut compani provid payer policymak
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
remain healthi compani anticip
billion convert revenu next
oper expens line expect
believ compani track improv oper
margin basi point free cash flow
weaker expect quarter neg
million due annual incent payment employe
higher capit expenditur headwind time
reimburs associ compani loyalti
program increas near-term capit expenditur
expect iqvia continu invest technolog
offer expect free cash flow normal
remaind year iqvia remain highli leverag
billion debt net leverag ratio time
gener clinic research
technolog segment concern
compani meet debt oblig
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
